- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/21 - Retroviridae, e.g. equine infectious anemia virus
Patent holdings for IPC class A61K 39/21
Total number of patents in this class: 1609
10-year publication summary
|
120
|
87
|
104
|
102
|
88
|
88
|
76
|
69
|
75
|
30
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Duke University | 3065 |
84 |
| The Trustees of the University of Pennsylvania | 4317 |
50 |
| The Scripps Research Institute | 1348 |
50 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2847 |
45 |
| International AIDS Vaccine Initiative | 90 |
43 |
| Triad National Security, LLC | 605 |
32 |
| Janssen Vaccines & Prevention B.V. | 295 |
29 |
| The Regents of the University of California | 19887 |
24 |
| Massachusetts Institute of Technology | 10041 |
24 |
| Beth Israel Deaconess Medical Center, Inc. | 857 |
22 |
| Centre National de La Recherche Scientifique | 10418 |
21 |
| American Gene Technologies International Inc. | 93 |
19 |
| Emory University | 1625 |
17 |
| Oregon Health & Science University | 760 |
17 |
| Glaxosmithkline Biologicals S.A. | 1637 |
16 |
| California Institute of Technology | 3972 |
15 |
| Baylor Research Institute | 236 |
15 |
| Inovio Pharmaceuticals, Inc. | 319 |
15 |
| Los Alamos National Security, LLC | 307 |
15 |
| New York University | 1743 |
15 |
| Other owners | 1041 |